Drug Trial Radar · NCT05305573
Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
Mar 25, 2022
Primary completion
Nov 14, 2023
Study completion Nov 14, 2023
Sponsor
- Lead sponsor
- Hipra Scientific, S.L.UIndustry
- Sponsor type
- Industry
- First posted
- Mar 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Phase IIb clinical trial to assess the Immunogenicity and Safety of a HIPRA's Candidate Booster vaccination (PHH-1V) in adults fully vaccinated with the adenovirus vaccine Vaxevria against COVID-19.
Conditions
- SARS-CoV-2 Infection
Interventions
COVID-19 Vaccine HIPRA 40 ug/doseBiological
Subjects will receive one injection of COVID-19 Vaccine HIPRA (PHH-1V)
Comirnaty (Pfizer-BioNtech) 30 ug/dose concentrate for dispersion for injectionBiological
Subjects will receive one injection of Comirnaty Vaccine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes of the immunogenicity against Omicron strain at Day 14Time frame: Day 14
- Safety and tolerability of PHH-1V as a booster doseTime frame: Day 7
- Safety and tolerability of PHH-1V as a booster doseTime frame: Day 28
- Safety and tolerability of PHH-1V as a booster doseTime frame: Day 182
- Safety and tolerability of PHH-1V as a booster doseTime frame: Day 182
- Safety and tolerability of PHH-1V as a booster doseTime frame: Day 182
- Safety and tolerability of PHH-1V as a booster doseTime frame: Days 14, 98 and 182
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Hospital HM Modelo
A Coruña, Spain
Hospital Gregorio Marañón
Madrid, Spain
Hospital HM Sanchinarro
Madrid, Spain
Hospital HM Puerta del Sur
Móstoles, Spain
Complejo Hospitalario Universitario de Santiago
Santiago de Compostela, Spain
Hospital HM Rosaleda
Santiago de Compostela, Spain
Complejo Hospitalario Universitario de Vigo
Vigo, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.